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Purpose: b catenin activation has been demonstrated to be pivotal in
chondrogenesis and a ﬁne balance of its levels is required to maintain
the healthy chondrocyte phenotype in adult articular cartilage. Never-
thless, if Wnt signalling cascade seems to be involved in osteoarthritis
(OA) development, a complete understanding of the downstream
mechanisms leading to b catenin activation and its effective role in the
disease is still missing. Among the effectors, the constitutive active
kinase GSK3b is the main regulator of intracellular b catenin levels.
GSK3b inhibition resulting in b catenin activation has been linked to OA
degeneration in rat model but emerging evidences suggest that human
cartilage might have different regulations of the Wnt pathway com-
pared to rodents. Thus, the aim of the study was to investigate the role
of GSK3b inhibition in human cartilage, to characterize its involvement
in OA development and progression, in particular to point out the
effective role in OA chondrocyte differentiation. Moreover, as GSK3b is
involved in other molecular pathways besides b catenin control, we
aimed at understanding the resulting effect of its inhibition in the
context of human chondrocytes and OA.
Methods: In order to characterize GSK3b in human OA cartilage, 9 tissue
samples of OA knee cartilage were analysed by immunoﬂuorescence (IF)
to assess levels of GSK3b inactive form (phospho-Ser9). In order to test
the effects of GSK3b inhibition on chondrocyte differentiation in vitro, 3D
cultures were established with P1 chondrocytes from 5 OA patients.
Micromasses were left to mature for one and two weeks in control
conditions (DMEM, 10%FBS, 50 mg/ml ascorbic acid), with the addition of
5mM LiCl or 10mM of SB216763 to inhibit GSK3b. Micromasses for
immunostainings were frozen in OCT. To evaluate differentiation pro-
gression, IF of nuclear localization of active b catenin and Runx2 was
performed with confocal microscopy. Mineralization was evaluated by
alizarin red staining and calcium quantitative assay on micromass sec-
tions or acidic extraction of insoluble extracts of the protein lysates,
respectively. Cell viability was evaluated by live and dead staining at the
end ofmicromassmaturation.Matrixmetalloproteinase (MMP-10,MMP-
13) expression was evaluated in lysates and starved supernatants with
western blotting and ELISA. In starved supernatants metalloprotease
activity was tested with collagen I and collagen II zymography.
Results: IF analyses of cartilage tissues for phospho-GSK3b expression
and localization revealed the presence of the inhibited form of GSK3b in
the cytoplasm of chondrocytes across the cartilage depth. In micro-
masses treated with GSK3b inhibitors we observed increased b catenin
and Runx2 nuclear translocation, with statistical signiﬁcance at 1 week,
supporting enhancement of differentiation. We also found signiﬁcantly
increased mineralization and number of dead cells after LiCl or
SB216763 mediated GSK3b inhibition, associated to a higher remodel-
ing of the micromass matrix structure. Indeed, GSK3b inhibition led to
increased expression and release in supernantants of MMP-10, known
to be a pivotal procollagenase activator in OA. Furthermore the
expression and activation of MMP-13, the main collagenase involved in
OA matrix remodelling, increased after GSK3b inhibition. Indeed,
zymography revealed a strongly increased metalloprotease activity
after GSK3b inhibition, against all tested substrates.
Conclusions: Collectively our data indicate that GSK3b inhibition in
human OA chondrocytes enhances differentation through hypertrophic
phenotype toward terminal stage. GSK3b inhibition heavily impacts on
extracellular matrix remodelling, inducing increased metalloproteases
expression and activation.Figure 1. (a) Human (H) and bovine (B) aggrecan (A1D1) fragments
detected by Western blot after incubation with or without human or
bovine synovial ﬂuid (SF) and joint capsule (JC). (b) Aggrecanase cleavage
sites in human and bovine aggrecan and fragments produced after
digestion are shown.Acknowledgement:
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CAPABLE OF DEGRADING AGGRECAN?
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Purpose: Trauma induces a cascade of events in the joint, which can
result in proteolytic degradation of the cartilage and OAwhere aggrecan
is one of the ﬁrst components to be degraded. It has been proposed that
aggrecan can be further degraded by proteases in the synovial ﬂuid (SF)
environment and that the joint capsule (JC), including the synovium,
can be a source of proteases. We aimed to investigate if the JC contains
proteases which are capable of degrading aggrecan and if there are
differences in the capacity to degrade aggrecan between healthy bovine
SF and SF from joints of injured patients.
Methods: Adult human aggrecan (from arthroplasty OA knee cartilage)
and immature bovine aggrecan (from the cartilage of the patellofemoral
groove of a 1-2 week old calf) were puriﬁed by CsCl density gradient
centrifugation to collect the A1D1 fraction. Human SF was aspirated
from two patients with knee injury, and SF and JC were collected from
healthy joints of 1-2 week old calf. SF (human or bovine) was added to
aggrecan (human or bovine), and JC was added to bovine aggrecan and
incubated for 1 h or 24 h at 37oC. The aggrecan fragments were then
puriﬁed by Alcian blue precipitation, deglycosylated, separated on SDS-
PAGE and visualized by Western blot using anti-aggrecan neoepitope
antibodies ARGS, FFGV and antibodies against the aggrecan G3 domain.
Results: Incubation of human or bovine aggrecan with bovine SF
showed that large aggrecan fragments were degraded and shorter G3
(GRGT-, GLGS-, AGEG- and LGQR-G3) and ARGS (ARGS-Chondroitin
sulfate 1 and/or 2 regions (CS1/CS2)) fragments were generated (Fig. 1).
Incubation of human or bovine aggrecan with human SF showed vir-
tually the same aggrecan fragmentation pattern as was observed for the
bovine SF, although the aggrecanase activity against the interglobular
domain (IGD) site (seen as ARGS fragments) in bovine aggrecan seems
to be less than against the human aggrecan IGD site. (Fig. 1). One hour
incubation of bovine A1D1 with JC resulted in low aggrecanase activity,
although after 24h incubation all full length aggrecan monomers had
been cleaved and were detected on Western blot as newly formed
AGEG-, LGQR-, ARLE-G3 and ARGS-CS1/CS2 fragments (Fig. 1). No or
only minor increases in FFGV fragments that indicate MMP activity
were seen on Western blot after incubation of human or bovine
aggrecan with human or bovine SF or with JC (data not shown).
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S137Conclusions: Bovine SF from joints of healthy calves contains active
aggrecanases that are capable of cleaving both adult human and
immature bovine aggrecan in the IGD and in the CS2 region. Human SF
from knees of adult injured patients, has the same ability to cleave in
the CS2 region of both immature bovine and adult human aggrecan, but
may have less activity against the bovine aggrecan IGD site. The
cleavage seen in the IGD and the CS2 region of bovine aggrecan after
incubationwith JC is a delayed process that may involve additional time
for diffusive transport of aggrecanases out of the JC, as well as time
needed for induction or activation of the aggrecanases.
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EVALUATING CATHEPSIN ACTIVITY AND SIRT1 CLEAVAGE IN
EXPERIMENTAL OSTEOARTHRITIS
L. Ben-Aderet, G. Blum, M. Dvir-Ginzberg. Hebrew Univ. of Jerusalem,
Jerusalem, Israel
Purpose: SIRT1 is a NAD-dependent protein deacetylase that regulates
cartilage matrix gene expression and was found to be impaired in
protein levels and enzymatic activity in OA vs. normal cartilage. Stim-
ulation of chondrocytes with pro-inﬂammatory factors induces site-
speciﬁc cleavage of full-length SIRT1 (110kDa) to generate an inactive
variant (75SIRT1;:75kDa). This research aims to proﬁle variations in
SIRT1 cleavage fragments and cathepsin B and S activities to determine
the inﬂammatory and catabolic state of cartilage and susceptibility to
develop Osteoarthritis (OA).
Methods: OA derived articular chondrocytes were obtained from total
knee arthroplasty. Following isolation and propagation, primary human
chondrocytes where either plated (2D) or encapsulated in three
dimensional (3D) alginate micro-beads and cultured in DMEM culture
media for 2-weeks. Chondrocytes were treated or untreated with 2 ng/
ml IL-1b and 50 ng/ml TNF-a for 24h. Following stimuli, cell extracts
and media were obtained and analyzed for SIRT1 cleavage or for cath-
epsin activity using activity based probes (ABPs), which covalently bind
active cathepsin B and S and exert a ﬂuorescent signal. Further, media
from round 4-mm-diameter human articular cartilage explants, sub-
jected to cyclic mechanical loading (60 N, 0.1 Hz, 1 h) in the presence or
absence of 2 ng/ml IL-1ß and 50 ng/ml TNF-a, were analyzed similarly.
Finally, regions of intact cartilage (IC) vs. degenerative cartilage (DC)
were cryo-sectioned and stained with ﬂuorescent ABPs to detect tem-
poral changes in cathepsin B and S activities as a function of articular
cartilage degeneration.
Results: Chondrocyte lysates from monolayer 2D and 3D cultures,
exhibited reduced protein levels of full length SIRT1 (110kDa), with
enhanced levels of 75SIRT1 and a :35kDa SIRT1-responsive fragment,
when subject to proinﬂammatory stimuli. Conditioned media from 2D
chondrocytes exhibited 3-fold enhancement in 75SIRT1 and :35kDa
SIRT1-responsive fragment with full-length SIRT1 being beneath the
limit of detection, under proinﬂammatory conditions. These data cor-
relate with enhanced mRNA expression levels of cartilage degrading
enzymes upon cytokine stimuli in both 2D and 3D chondrocytes (i.e.
average increase of 160-fold for MMP13; 3-fold for ADAMTS5, 6-fold for
cathepsin B, and 50-fold for cathepsin S), and reduced expression for
cartilage structural genes (i.e. average reduction of 2-fold for both
COL2A1 and ACAN). Analysis of cathepsin activity with ABPs in cell
lysates, showed 2-5 fold enhancement of enzymatic activity of cathe-
psin S with insigniﬁcant changes in cathepsin B activity. In addition,
conditioned media obtained from plated chondrocytes showed
enhanced cathepsin S activity with undetected cathepsin B activity.
While both cathepsins showed augmented activity in freshly isolated
chondrocytes from IC and DC, surprisingly, only cathepsin S was
observed in supernatant media following collagenase treatment in DC
regions of OA cartilage, indicating active cathepsin S is secreted by
chondrocytes and contributes to extracellular matrix degradation.
Conclusions: In summery, our in-vitro data indicate that the 75SIRT1
fragment is augmented in lysates and conditioned media of plated
chondrocytes under proinﬂammatory conditions. As well, cathepsin
activity, especially cathepsin S, is augmented in chondrocytes, subject to
proinﬂammatory stimuli. These data are further supported by the
enhanced activity of cathepsin S in degenerated cartilage matrix. Hence
these ﬁndings may provide a basis for early detection of OA susceptible
individuals, based on enhanced cathepsin activity and SIRT1 cleavage,
generated in regions of articular cartilage prone to damage.219
DEPLETION OF SIRT6 CAUSES CELLULAR SENESCENCE, DNA DAMAGE,
AND TELOMERE DYSFUNCTION IN HUMAN CHONDROCYTES
K. Nagai, T. Matsushita, T. Matsuzaki, K. Takayama, A. Uefuji, S. Zhang,
N. Nakano, T. Matsumoto, R. Kuroda, M. Kurosaka. Dept. of Orthopaedic
Surgery, Kobe Univ. Graduate Sch. of Med., Kobe, Japan
Purpose: Recently, it has been suggested that chondrocyte senescence
plays an important role in the pathogenesis and development of
Osteoarthritis (OA). SIRT6 is a member of sirtuin family of NADþ-
dependent protein deacetylase. Recently, SIRT6 has been implicated in
DNA repair, telomere maintenance, attenuation of inﬂammation and
glucose homeostasis. Notably studies in mice have shown that SIRT6
deﬁciency produces premature aging phenotypes, whereas SIRT6
overexpression causes a moderate increase in the lifespan of male mice,
strongly suggesting an important role of SIRT6 in aging and aging-
associated diseases. However, its role in chondrocytes has so far not
been explored. The purpose of this study is to examine the role of SIRT6
in human chondrocytes by inhibiting SIRT6 with a RNA interference
(RNAi) technique. The hypothesis of the present study is that SIRT6 has
a protective function toward human chondrocytes
Methods: OA cartilage tissues were obtained from varus knee OA dur-
ing total knee arthroplasty. Lateral and medial femoral condyles were
used as cartilage with mild and severe OA, respectively. Articular car-
tilage tissues without OA were obtained from the patients underwent
surgery for femoral neck fracture. These were used for histological
experiments. Next, SIRT6 was depleted by RNAi and examined the
inﬂuence of SIRT6 depletion on gene expression changes, proliferation,
and senescence in normal human chondrocytes. Normal Human
Articular Chondrocytes-knee (NHAC-kn) was used as a normal human
chondrocytes. RNA or proteins were extracted 48 hours after the lip-
ofection, and real-time PCR and western blotting analysis were
respectively performed. The proliferation activity was examined using a
Cell Counting Kit-8. Optical density was measured at 0, 24, 48, 72, 96
hours after the lipofection. Senescence associated b-Galactosidase (SA-
b-Gal) staining was examined using a SA-b-Gal staining kit. Fur-
thermore, to detect DNA damage and telomere dysfunction, the gH2AX
foci and telomere dysfunction-induced foci (TIFs) where gH2AX foci co-
localized with telomere repeat binding factor-1 (TRF-1) were examined
using an immunoﬂuorescence confocal microscopy.
Results: Immunohistochemical analysis showed that SIRT6-positive
cells were observed in normal cartilage, and mild and severe OA carti-
lage. In real-time PCR analysis, the depletion of SIRT6 signiﬁcantly
increased expression of matrix metalloproteinase (MMP) -1 and 13
mRNA. The proliferation assay showed that the absorbance was sig-
niﬁcantly decreased by the depletion of SIRT6 at 72 and 96 hours after
lipofection, indicating reduced proliferation by the depletion of SIRT6.
SA-b-Gal assay showed that the percentage of SA-b-Gal positive cells
was signiﬁcantly increased by the depletion of SIRT6, indicating that the
depletion of SIRT6 induced premature senescence. Immuno-
ﬂuorescence microscopic analysis showed that gH2AX foci and TIFs was
signiﬁcantly increased in the SIRT6-depleted chondrocytes compared
with control. Furthermore, to examine the downstream signaling
pathways that mediate the induction of senescence by the depletion of
SIRT6, the protein level of mediators for DNA damage induced-sen-
escence, p16 and p21, was examined by western blotting. p16 protein
level was increased while p21 protein level was reduced in the in SIRT6-
depleted chondrocytes compared with control.
Conclusions: The present study demonstrated that the depletion of
SIRT6 in human chondrocytes caused increased expression of MMP-1
and 13, reduced proliferation and increased senescent cells. In addition,
the depletion of SIRT6 caused accumulation of gH2AX and TIFs. These
observations suggested that the depletion of SIRT6 induced premature
senescence associated with a secretory phenotypic change and that the
induction of the premature senescence may be caused by increased
DNA damages and telomere dysfunction. Moreover, we observed p16
was increased by SIRT6 depletion. The p16-pRB pathway has been
reported to be a major pathways that mediate premature senescence
and proliferation arrest. Therefore taken together, these observations
suggest the depletion of SIRT6 in human chondrocytes caused DNA
damage and telomere dysfunction, followed by a premature senescence
possibly via the p16-pRB pathway. SIRT6 may play an important role to
protect chondrocytes from premature senescence, DNA damage, and
telomere dysfunction.
